The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

In this Diabetes in Real Life column, Susan Weiner, MS, RDN, CDN, CDCES, FACES, talks with Michael See, MS, CDCES, ACSM-CEP, NBC-HWC, about tips for exercise for people living with diabetes. Weiner: ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

The drug helped lower patients’ blood sugar and reduce their weight by an average of 16 pounds.

People diagnosed with type 2 diabetes might benefit soon from Eli Lilly's new orforglipron weight loss drug following its ...

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

Lilly plans to submit orforglipron for approval in weight management by the end of 2025, with a T2D application to follow in ...

The results bring Eli Lilly's pill orforglipron one step closer to becoming a new, needle-free alternative in the booming ...

and it is no different for working women with diabetes. A sedentary life, stress, and irregular meal habits can complicate maintaining a stable blood glucose level. However, a proper exercise ...

Running is one of the most effective outdoor exercises for weight loss. A study published in the Journal of Strength and Conditioning Research shows that running burns roughly twice the number of ...